Suscribirse

Continuous compression with asynchronous ventilation improves CPR prognosis? A meta-analysis from human and animal studies - 13/01/23

Doi : 10.1016/j.ajem.2022.11.003 
Mengxue Sun a, b, Aiqun Zhu b, c, , Yangyang Tang a, b
a Xiangya Nursing School of Central South University, Changsha, Hunan, China 
b Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China 
c Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China 

Corresponding author at: Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University; Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Renmin Middle Road, No. 139, Changsha, Hunan 410000, China.Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South UniversityDepartment of Emergency MedicineThe Second Xiangya Hospital of Central South UniversityRenmin Middle Road, No. 139ChangshaHunan410000China

Abstract

Background

The cardiopulmonary resuscitation (CPR) compression to ventilation strategy remains controversial. We conducted a meta-analysis to compare the outcomes between continuous chest compressions CPR with asynchronous ventilation (CCC-CPR) and interrupted chest compressions CPR with synchronous ventilation (ICC-CPR) in cardiac arrest.

Methods

PubMed, Web of Science, Embase, MEDLINE (Ovid/LWW) and the Cochrane Libraries were searched up from inception to July 31, 2022. Human and animal studies comparing CCC-CPR versus ICC-CPR were included. Outcome variables were return of spontaneous circulation (ROSC), time to ROSC, survival to discharge, 1-month survival, survival at 4 h, good neurological function, mean arterial pressure (MAP) and other clinical parameters. Jadad Scale and Newcastle-Ottawa Scale were used to assess the study quality and risk of bias.

Results

The systematic search identified eight studies on humans and twelve studies on animal trials. There were no significant differences in ROSC (odd ratios [OR] 1.07; 95% confidence interval [CI]: 0.86–1.32; P = 0.55), survival to hospital discharge (OR 1.04; 95%CI 0.77–1.42; P = 0.79), 1-month survival (OR 1.07; 95%CI 0.84–1.36; P = 0.57), and good neurological outcome (OR 0.92; 95%CI 0.84–1.01, P = 0.09) between CCC-CPR and ICC-CPR in human studies. In animal trials, CCC-CPR had significantly higher rate of ROSC (OR = 1.81; 95% CI: 0.94–3.49; P = 0.07), survival at 4 h (OR 2.57; 95% CI: 1.16–5.72; P = 0.02) and MAP (mean difference [MD] 0.79, 95% CI: 0.04–1.53; P = 0.04), even though no significant differences in ROSC time, arterial potential of hydrogen (pH) and partial tension of carbon dioxide (PaCO2).

Conclusion

CCC-CPR did not show superiority in human outcomes compared with ICC-CPR, but its effect value was significantly increased in animal experiments. We should take the positive outcomes from animals and apply them to human models, and more physiological mechanisms need to be confirmed in CPR patients with different compression-ventilation strategies to improve the prognosis of cardiac arrest.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiopulmonary resuscitation, Cardiac arrest, Continuous chest compression, Interrupted chest compression, Asynchronous ventilation, Synchronous ventilation


Esquema


© 2022  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 64

P. 26-36 - février 2023 Regresar al número
Artículo precedente Artículo precedente
  • Aerosol containment device design considerations and performance evaluation metrics
  • Rachael M. Jones, Niles Andrus, Thomas Dominguez, Jeremy Biggs, Brian Hansen, Frank A. Drews
| Artículo siguiente Artículo siguiente
  • Institutional response to the 2022 iodinated contrast shortage: A narrative review
  • Abigail Rosander, Ryan Andrade, Jennifer Concepcion, Lucille Woodley, Will Havron, Adel Elkbuli

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.